Introduction
C. pneumoniae causes approximately 10% of community-acquired pneumonia and 5% of pharyngitis, bronchitis, and sinusitis. The clinical symptoms of C. pneumoniae pulmonary infections are similar to those caused by other respiratory pathogens, except for a few distinguishing features. Antibodies against C. pneumoniae are rare in children under the age of 5, except in developing and tropical countries. Antibody prevalence increases rapidly at ages 5 to 14, reaches 50% at the age of 20, and continues to increase slowly to 70% to 80% at ages 60 to 70. The SeroCP™ product line is a well-known and established ELISA based assay for qualitative detection of antibodies to Chlamydia pneumoniae in human serum.
Features
- Highly purified C. pneumoniae (TWAR-183) elementary bodies as antigens
- Species-specific
- High sensitivity and specificity
- Complete serological profile – IgG, IgM, IgA
- Serum samples
SeroCP IgG Cat# A191-01
SeroCP IgM Cat# A192-01
SeroCP IgA Cat# A193-01
